生命科学资讯

Eli Lilly’s triple-G obesity readout; The latest Endpoints 100 results; Public biotechs cash in; and more

BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp Raises Stock Position in Agilent Technologies, Inc. $A - MarketBeat

Bellevue Group AG Buys 95,754 Shares of 10x Genomics $TXG - MarketBeat

Thermo Fisher Scientific Inc. $TMO Shares Sold by Banque Transatlantique SA - MarketBeat

Agilent Technologies, Inc. $A Stock Position Lowered by Balyasny Asset Management L.P. - MarketBeat

4D Advisors LLC Purchases Shares of 30,000 Illumina, Inc. $ILMN - MarketBeat

GAO probe finds understaffed FDA putting some medical device recall work on the 'back burner'

Lonza Group (OTCMKTS:LZAGY) Sees Unusually-High Trading Volume - What's Next? - MarketBeat

340B sales grew 23% last year, and court battle over pilot program intensifies

Covid vaccine deaths review sent to top of FDA, but with far less certain conclusions, sources say

Citi downgrades 10x Genomics (TXG) to a Hold - The Globe and Mail

Impulse Dynamics clinches $158M for chronic heart failure implant

Obesity biotech Zealand seeks partners to ‘take therapies directly to the brain’

A 2-speed payer transformation is underway

CHMP calls to reject Anavex's Alzheimer’s pill over impurities, side effects and weak efficacy

In the clinic for Dec. 12, 2025

Other news to note for Dec. 12, 2025

Regulatory actions for Dec. 12, 2025

Biopharma money raised: Jan. 1-Dec. 11, 2025

Money raised by biopharma